About us
Overview
Our strategy
Our leadership
How we’re funded
Our history
What we do
Overview
Our science
Therapeutics
Diagnostics development
Partnering with us
Funding, projects and partnerships
Available technologies
LifeArc Ventures
IP management and tech transfer
Policy and public affairs
Translational Challenges
Overview
Motor Neuron Disease
Chronic Respiratory Infection
Global Health
Antimicrobial Resistance
Neglected Tropical Diseases
Emerging Viral Threats
Rare Disease
Childhood Cancer
News and events
News
Events
Careers
Overview
Benefits and rewards
Early careers
Current vacancies
Contact us
Search
Toggle Menu
Search
Search
Search
Refine results
Content Type
Careers
Case Studies
Funding Calls
Other Technologies
Pages
People
Posts
Projects
Publications
Therapeutics
Topic
Company updates
Motor neuron disease
Chronic respiratory infection
Global health
Rare disease
Childhood cancer
Neurodegeneration
Policy and public affairs
Technology transfer
Our science
Ventures
Polymerase E10 for processing of CyDNA
Other Technology
15 August 2022
Read more
: Polymerase E10 for processing of CyDNA
Screening and evolution in emulsions
Other Technology
15 August 2022
Read more
: Screening and evolution in emulsions
Polymerase 5D4 engineered for bi-sulphite sequencing
Other Technology
15 August 2022
Read more
: Polymerase 5D4 engineered for bi-sulphite sequencing
Stabilised SARS-CoV-2 Spike protein variants
Other Technology
15 August 2022
Read more
: Stabilised SARS-CoV-2 Spike protein variants
LifeArc appoints Dr Ian Campbell as Chief Business Officer
Post
31 July 2020
Read more
: LifeArc appoints Dr Ian Campbell as Chief Business Officer
LifeArc joins forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to strengthen antimicrobial discovery efforts
Post
28 September 2022
Read more
: LifeArc joins forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to strengthen antimicrobial discovery efforts
Previous Page
1
…
8
9
10
Close Modal
WordPress development by
Andy White
using
PorterWP